Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD3 | P35462 | 16/20 | 0.74 |
| ▸ | DRD2 | P14416 | 11/20 | 0.74 |
| ▸ | DRD4 | P21917 | 6/20 | 0.74 |
| ▸ | DRD1 | P21728 | 3/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6980585 | 0.96 | DRD3 (0.77) | DRD3DRD2DRD4DRD1 | |
| SCHEMBL6978647 | 0.89 | DRD3 (0.78) | DRD3DRD2DRD4DRD1 | |
| SCHEMBL7976699 | 0.87 | DRD2 (0.93) | DRD3DRD2DRD4DRD1 | |
| SCHEMBL7976552 | 0.86 | DRD3 (0.80) | DRD3DRD2DRD4DRD1 | |
| SCHEMBL6975459 | 0.86 | DRD3 (0.82) | DRD3DRD2DRD4DRD1 | |
| SCHEMBL6979684 | 0.85 | DRD3 (0.76) | DRD3DRD2DRD4DRD1 | |
| SCHEMBL6981235 | 0.85 | DRD3 (0.65) | DRD3DRD2DRD4DRD1 | |
| SCHEMBL6981058 | 0.84 | DRD3 (0.62) | DRD3DRD2DRD4DRD1 | |
| SCHEMBL6981194 | 0.84 | DRD3 (0.62) | DRD3DRD2DRD4DRD1 | |
| SCHEMBL6975955 | 0.84 | DRD2 (1.00) | DRD3DRD2DRD4DRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6274593-B1 | TREATING PSYCHOLOGICAL DISORDERS, SCHIZOPHRENIA, AND PARKINSON*S DISEASE | SMITHKLINE BEECHAM P.L.C. (GB) | 2001-08-14 | — | — | US | claimed |
| EP-0980357-A1 | SUBSTITUTED TETRAHYDRO ISOQUINOLINES AS MODULATORS OF DOPAMINE D3 RECEPTORS | SMITHKLINE BEECHAM PLC (GB) | 2000-02-23 | — | — | EP | claimed |
| WO-1998050363-A1 | SUBSTITUTED TETRAHYDRO ISOQUINOLINES AS MODULATORS OF DOPAMINE D3 RECEPTORS | SMITHKLINE BEECHAM PLC (GB) | 1998-11-12 | — | — | WO | claimed |
| US-6274593-B1 | TREATING PSYCHOLOGICAL DISORDERS, SCHIZOPHRENIA, AND PARKINSON*S DISEASE | SMITHKLINE BEECHAM P.L.C. (GB) | 2001-08-14 | — | — | US | disclosed |
| EP-0980357-A1 | SUBSTITUTED TETRAHYDRO ISOQUINOLINES AS MODULATORS OF DOPAMINE D3 RECEPTORS | SMITHKLINE BEECHAM PLC (GB) | 2000-02-23 | — | — | EP | disclosed |
| WO-1998050363-A1 | SUBSTITUTED TETRAHYDRO ISOQUINOLINES AS MODULATORS OF DOPAMINE D3 RECEPTORS | SMITHKLINE BEECHAM PLC (GB) | 1998-11-12 | — | — | WO | disclosed |